New autoimmune drug VIS171 passes first safety check in humans
NCT ID NCT05418101
First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This early-stage study tested a new drug called VIS171 in 61 people, first in healthy volunteers and then in patients with autoimmune diseases. The main goal was to check safety and how the body processes the drug. Results will help decide if further testing is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ambulatory for Specialized Medical Help - skin and venereal diseases
Sofia, 1407, Bulgaria
-
Clinical republican Hospital
Chisinau, MD 2025, Moldova
-
Comac Medical Ltd
Sofia, 1612, Bulgaria
-
Diagnostic and Consultative Center Convex EOOD
Sofia, 1680, Bulgaria
-
MBAL Sveta Sofia
Sofia, 1618, Bulgaria
-
New Zealand Clinical Research
Christchurch, 8011, New Zealand
-
Radboud University Medical Center
Gelderland, 6525, Netherlands
-
UMHAT
Plovdiv, 4002, Bulgaria
-
Universitaetsklinikum Bonn AöR
Bonn, 53127, Germany
-
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz
Rheinland-Pfalz, 55131, Germany
Conditions
Explore the condition pages connected to this study.